These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21351153)

  • 21. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
    Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
    Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction.
    Meltzer CC; Smith G; Price JC; Reynolds CF; Mathis CA; Greer P; Lopresti B; Mintun MA; Pollock BG; Ben-Eliezer D; Cantwell MN; Kaye W; DeKosky ST
    Brain Res; 1998 Nov; 813(1):167-71. PubMed ID: 9824691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
    Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
    Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A
    Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
    Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
    Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [(18)F]setoperone PET study.
    Gerretsen P; Graff-Guerrero A; Menon M; Pollock BG; Kapur S; Vasdev N; Houle S; Mamo D
    Soc Neurosci; 2010; 5(4):375-83. PubMed ID: 20198536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
    Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
    Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population.
    Moses-Kolko EL; Price JC; Shah N; Berga S; Sereika SM; Fisher PM; Coleman R; Becker C; Mason NS; Loucks T; Meltzer CC
    Neuropsychopharmacology; 2011 Dec; 36(13):2729-40. PubMed ID: 21849982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
    Hinz R; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):161-72. PubMed ID: 16685260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic density in healthy human aging is not influenced by age or sex: a
    Michiels L; Delva A; van Aalst J; Ceccarini J; Vandenberghe W; Vandenbulcke M; Koole M; Lemmens R; Laere KV
    Neuroimage; 2021 May; 232():117877. PubMed ID: 33639258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
    Hautzel H; Müller HW; Herzog H; Grandt R
    Neuroimage; 2011 Oct; 58(3):905-11. PubMed ID: 21722741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study.
    Frey BN; Rosa-Neto P; Lubarsky S; Diksic M
    Neuroimage; 2008 Aug; 42(2):850-7. PubMed ID: 18583156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction.
    Giovacchini G; Toczek MT; Bonwetsch R; Bagic A; Lang L; Fraser C; Reeves-Tyer P; Herscovitch P; Eckelman WC; Carson RE; Theodore WH
    J Nucl Med; 2005 Jul; 46(7):1128-35. PubMed ID: 16000281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps.
    Svarer C; Madsen K; Hasselbalch SG; Pinborg LH; Haugbøl S; Frøkjaer VG; Holm S; Paulson OB; Knudsen GM
    Neuroimage; 2005 Feb; 24(4):969-79. PubMed ID: 15670674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use.
    Erritzoe D; Frokjaer VG; Haugbol S; Marner L; Svarer C; Holst K; Baaré WF; Rasmussen PM; Madsen J; Paulson OB; Knudsen GM
    Neuroimage; 2009 May; 46(1):23-30. PubMed ID: 19457377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.
    Stenbaek DS; Kristiansen S; Burmester D; Madsen MK; Frokjaer VG; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2019 May; 40(7):2117-2124. PubMed ID: 30633430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
    Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
    J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.